How many UTIs constitute a recurrent UTI?

A recurrent UTI is medically defined as two or more confirmed urinary tract infections within a 6-month period, or three or more infections within a 12-month period.

Why do I keep getting UTIs even after taking antibiotics?

Recurrent UTIs despite antibiotic treatment can occur due to antibiotic resistance, reinfection, incomplete eradication, or underlying anatomical or hormonal factors. A specialist evaluation with urine culture is essential.

Can recurrent UTIs be prevented?

Yes - recurrent UTIs can often be significantly reduced or eliminated with the right prevention strategy including low-dose antibiotic prophylaxis, vaginal estrogen therapy for postmenopausal women, behavioral modifications, and evidence-based supplements.

Do I need to see an infectious disease specialist or can my primary care doctor treat recurrent UTIs?

While primary care physicians can treat individual UTI episodes, recurrent UTIs benefit significantly from infectious disease specialist evaluation with specialized training in antibiotic resistance patterns and evidence-based prevention strategies.

Is long-term antibiotic use for UTI prevention safe?

Low-dose antibiotic prophylaxis for recurrent UTI prevention has a well-established safety record when properly managed. Specialists carefully select the safest antibiotic at the lowest effective dose and regularly reassess.

Does Atlas IDP accept insurance for recurrent UTI treatment?

Yes, Atlas Infectious Disease Practice accepts most major insurance plans. Call (561) 995-6971 to verify your specific insurance coverage before your appointment.

Outbreaks News Archives

Login / Signup

Early Release – Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Escherichia coli Sequence Type 131-H22 in Parrots from Illegal Pet Trade, Brazil, 2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Seoul Virus Infection Acquired at Private Pet Rat Breeding Facility, Germany, 2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Antimicrobial-Resistant Clonal Complex 11 Neisseria meningitidis–Associated Urethritis Cluster, Thailand – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Genomic Investigation of Disseminated Gonococcal Infections, Minnesota, USA, 2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Fatal Pneumocephalus Caused by Hypervirulent Klebsiella pneumoniae, Germany – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Jorge Lobo’s Disease in Child with Tick Exposure, Brazil – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Zoonotic Baylisascaris procyonis Infection in Raccoons, Mississippi, USA, 2023–2024 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Genetic Cluster of Extended-Spectrum β-lactamase–Producing Klebsiella pneumoniae in Humans and Food, Switzerland, 2018–2019 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Early Release – Emergence and Polyclonal Dissemination of blaNDM-7–Carrying InX3 Plasmid in Enterobacter cloacae Complex, France, 2021–2023 – Volume 31, Number 10—October 2025 – Emerging Infectious Diseases journal

Schedule an Appointment

Quick Links

Patient Forms

Contact Us